Completed PHASE3 INTERVENTIONAL 4-arm NCT00554164

Positron Emission Tomography Guided Therapy of Aggressive Non-Hodgkin's Lymphomas (PETAL)

Sponsor: Deutsche Krebshilfe e.V., Bonn (Germany)

Interventions (R-)CHOP protocol B-ALL protocol

Updated 6 times since 2017 Last updated: May 4, 2017 Started: Nov 30, 2007 Primary completion: Mar 31, 2017 Completion: Mar 31, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Lymphoma, High-grade, this trial is completed. The trial is conducted by Deutsche Krebshilfe e.V., Bonn (Germany) and has accumulated 6 data snapshots since 2007. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Jun 2017 — Jun 2018 [monthly]

Completed PHASE3

Status: Active Not Recruiting → Completed

▶ Show 1 earlier version

Jan 2017 — Jun 2017 [monthly]

Active Not Recruiting PHASE3

First recorded

Nov 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Deutsche Krebshilfe e.V., Bonn (Germany)
University Hospital, Essen

Data source: University Hospital, Essen

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Essen, Germany